Европска Унија - Естонски - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.

Европска Унија - Естонски - EMA (European Medicines Agency)

accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Естонија - Естонски - Ravimiamet

sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 20mg 12tk; 20mg 56tk

Естонија - Естонски - Ravimiamet

sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 50mg 60tk

Естонија - Естонски - Ravimiamet

sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 70mg 56tk; 70mg 60tk

Естонија - Естонски - Ravimiamet

sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 80mg 30tk; 80mg 10tk

Естонија - Естонски - Ravimiamet

sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 100mg 30tk; 100mg 10tk

Естонија - Естонски - Ravimiamet

sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 140mg 30tk; 140mg 10tk

Европска Унија - Естонски - EMA (European Medicines Agency)

krka - olansapiin - schizophrenia; bipolar disorder - psühhoeptikumid - olansapiin on näidustatud skisofreenia raviks. olansapiin on efektiivne, säilitades kliinilist paranemist ajal jätkamine ravi patsientidel, kes on näidanud, esialgne ravi vastuseks. olansapiin on näidustatud ravi mõõduka kuni raske maniakaalse episoodi. patsientidel, kelle maniakaalne episood on vastanud, et olansapiin-ravi, olansapiin on näidustatud kordumise ennetamiseks patsientidel, kellel on bipolaarne häire.

Европска Унија - Естонски - EMA (European Medicines Agency)

apotex europe bv - olansapiin - schizophrenia; bipolar disorder - psühhoeptikumid - olansapiin on näidustatud skisofreenia raviks. olansapiin on efektiivne, säilitades kliinilist paranemist ajal jätkamine ravi patsientidel, kes on näidanud, esialgne ravi vastuseks. olansapiin on näidustatud ravi mõõduka kuni raske maniakaalse episoodi. patsientidel, kelle maniakaalne episood on vastanud, et olansapiin-ravi, olansapiin on näidustatud kordumise ennetamiseks patsientidel, kellel on bipolaarne häire.